This Month in Psychopharmacology

Paternal Perinatal Depression, Anxiety, and Stress and Child Development

While maternal perinatal mental health has long been a focus of res...

Read More

Lithium Versus Quetiapine Augmentation For Treatment-Resistant Depression

A major randomized controlled trial compared the long-term clinical...

Read More

New Study Links Psychiatric Medications to Increased Risk of Amyotrophic Lateral Sclerosis

A recent study reveals a notable association between the use of com...

Read More

Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings

A comprehensive systematic review reexamines the long-term conseque...

Read More

Benzgalantamine Approved For The Treatment Of Mild-To-Moderate Alzheimer’s Disease

The FDA has approved benzgalantamine, a novel oral prodrug of galan...

Read More

Fremanezumab Offers Dual Relief for Patients with Migraine and Major Depression

A growing body of evidence highlights the complex bidirectional rel...

Read More

Esketamine Combinations in TRD: SNRI vs SSRI Outcomes

In a large real-world comparative effectiveness study involving ove...

Read More

Psilocybin and Escitalopram Show Distinct Brain Effects in Depression Treatment

A new randomized controlled trial directly compared the brain effec...

Read More

Stimulant Medication Use and Risk of Psychotic Experiences

Recent post marketing surveillance and observational studies have s...

Read More

Valbenazine in Elderly Adults with Tardive Dyskinesia

The use of antipsychotics in geriatric patients is complicated by t...

Read More

Comparative Cardiovascular Safety of ADHD Medications

Concerns about the cardiovascular safety of medications used for th...

Read More

FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease

The FDA has approved the first blood-based test to help diagnose Al...

Read More